ALC
ALCIDION GROUP LIMITED
$0.1000
0.00%
Market cap
$135M
Turnover
$82,430
Last price
$0.1000
Day change
0.00%
Announcements
13
Range, past year
Open 0.093 · Low 0.079 · Now 0.100 · High 0.145
Open ALC in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
ALC momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
31/100
Wyckoff phase
Downtrend4d
Trend stage
Breakdown
1 Day
+0.0%
1 Week
+0.0%
1 Month
+0.0%
1 Year
+7.5%
RSI
49
Avg daily range
5.3%
ALCIDION GROUP LIMITED scores 31 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 4 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- Thin liquidity
- Risk rating: High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsALC announcements
Recent price-sensitive releases.
- 2026-10-09 2026 Notice of Annual General Meeting Capital Reconstruction | Notice of Annual General Meeting | Proxy Form
- 2026-10-09 Proposed Consolidation of Capital Capital Reconstruction
- 2026-09-30 Northern Care Alliance to implement ALC's Miya Precision Progress Report
- 2026-08-19 FY26 Results Release Web Cast | Preliminary Final Report
- 2026-08-19 FY26 Results Presentation Company Presentation | Preliminary Final Report
- 2026-08-19 FY26 Appendix 4E and Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-23 Q4 FY26 Quarterly Activities Report and Appendix 4C
More Health Care stocks
Most traded in the same sector.